Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Anthony Welters

At a glance: Anthony Welters is Director at Gilead Sciences (GILD). Their latest SEC Form 4, filed Aug 27, 2026, reported a sale of $462K. On file: 0 purchase lines ($0) and 4 sale lines ($2.7M).

Disclosed holdings: about $2.2M of GILD stock: 12,894 shares reported on their latest Form 4 (filed Aug 27, 2026), valued at the Nov 19, 2026 close of $167.13. This counts only GILD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Gilead Sciences, Inc. (GILD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.7M

Anthony Welters's InsiderPrint

4 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Anthony Welters: 4 trades, 2026 to 20262026: 0 buys, 4 sales

Reading this print: Almost only sells, trading about 4 times a year, typically $685K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (4)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Deanna D. Strable-SoethoutCEO, President · PFG · 100% match
  2. Daniel E. BrownCEO, President · CHRD · 100% match
  3. Tracy LiuDirector · ACMR · 100% match
  4. Tsun Yee LawDirector · NNE · 100% match
  5. Samantha HarnettGeneral Counsel · LOGI · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Aug 27SEC GILDGilead Sciences, Inc. Sell Plan 3,11817,494 held (−15%) $148.31 $462K +12.7%
Aug 27SEC GILDGilead Sciences, Inc. Sell Plan 4,60012,894 held (−26%) $148.82 $685K +12.3%
Aug 27SEC GILDGilead Sciences, Inc. Sell Plan 3,40219,774 held (−15%) $148.24 $504K +12.7%
Aug 27SEC GILDGilead Sciences, Inc. Sell Plan 6,88012,894 held (−35%) $148.82 $1.0M +12.3%
  • Sell

    Director Anthony Welters sold $462K of GILD at $148.31 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Anthony Welters sold $685K of GILD at $148.82 — cuts the stake by 26%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Anthony Welters sold $504K of GILD at $148.24 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Anthony Welters sold $1.0M of GILD at $148.82 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.

Follow Anthony Welters

Get one email when Anthony Welters files a new purchase or sale. Free.

At most one email a day about Anthony Welters, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.